We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » FDA Likely to Make Rx Counterfeit Pedigree Policy Decision in May
FDA Likely to Make Rx Counterfeit Pedigree Policy Decision in May
March 10, 2006
The FDA is expected to make a decision in May about whether to implement long-delayed pedigree requirements for drugmakers to combat counterfeit prescription drugs, according to a top agency official.